HomeSUVENPHAR • NSE
add
Suven Pharmaceuticals Ltd
Previous close
₹1,125.20
Day range
₹1,076.50 - ₹1,135.00
Year range
₹598.00 - ₹1,360.00
Market cap
276.69B INR
Avg Volume
325.11K
P/E ratio
99.48
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 3.07B | 39.73% |
Operating expense | 1.54B | 147.52% |
Net income | 828.80M | 77.27% |
Net profit margin | 26.98 | 26.85% |
Earnings per share | — | — |
EBITDA | 1.10B | 72.33% |
Effective tax rate | 24.10% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.56B | -12.96% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 20.28B | — |
Shares outstanding | 254.23M | — |
Price to book | 14.48 | — |
Return on assets | — | — |
Return on capital | 11.77% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 828.80M | 77.27% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1989
Website
Employees
1,052
